ParagraphFour.com | gregoryglass | Activity https://paragraphfour.com/members/gregoryglass/activity/ Activity feed for gregoryglass. Fri, 10 Apr 2026 22:10:38 -0400 https://buddypress.org/?v= en-US 30 hourly 2 11d999fd19af71eb673ea28e0b93eb32 gregoryglass updated 'Trokendi XR®(topiramate) Extended-release Capsules ': Trokendi XR®(topiramate) Extended-release Capsules Company […] https://paragraphfour.com/activity/p/11813/ Thu, 09 Apr 2026 15:02:29 -0400 Trokendi XR®(topiramate) Extended-release Capsules
Company SUPERNUS
Date of First Filing April 3, 2014 (200mg) and May 12, 2014 (25, 50, and 100mg)

Paragraph IV Applicant: Actavis
Case Name: SUPERNUS PHARAMCEUTICALS INC v. ACTAVIS INC et al
Court/Case #: New Jersey District Court (njdc) 2:2014cv06102
Date Filed: 10/1/14
Judge: Wigento…Read more

]]> 0 94d9b8334057b94898fda5d12487fdb9 gregoryglass updated 'Rytary®(carbidopa and levodopa) ER Capsules ': Rytary®(carbidopa and levodopa) Extended-release […] https://paragraphfour.com/activity/p/11811/ Thu, 09 Apr 2026 14:53:19 -0400 Rytary®(carbidopa and levodopa) Extended-release Capsules
Company IMPAX LABS
Date of First Filing June 10, 2015 (61.25 mg/245 mg) and June 24, 2015 (23.75 mg/95 mg, 36.25 mg/145 mg, 48.75 mg/195 mg)

Paragraph IV Applicant: Actavis
Case Name: IMPAX LABORATORIES INC v. ACTAVIS LABORATORIES FL INC et al
Court/Case #: New Jersey District…Read more

]]> 0 3ebc1a4a63742b466521e2c05f564538 gregoryglass updated 'Lumigan®(bimatoprost) Ophthalmic Solution ': Lumigan®(bimatoprost) Ophthalmic Solution Company ALLERGAN […] https://paragraphfour.com/activity/p/11808/ Thu, 09 Apr 2026 14:42:37 -0400 Lumigan®(bimatoprost) Ophthalmic Solution
Company ALLERGAN
Date of First Filing December 22, 2008 (0.03%) and April 5, 2011 (0.01%)

Paragraph IV Applicant: Barr
Case Name: ALLERGAN INC. v. BARR LABORATORIES INC.
Court/Case #: Court of Appeals for the Federal Circuit (cafc) 12-1040
Date Filed: 10/21/2011
Judge: Wallach, Rader,…Read more

]]> 0 8068725a8a3ca6ff8efb5c744fbdefb0 gregoryglass updated 'Generic Companies Report #3 (Q-Z) ': The Paragraph Four Report ® Generic Companies Report #3 […] https://paragraphfour.com/activity/p/11806/ Thu, 09 Apr 2026 14:35:49 -0400 The Paragraph Four Report ®
Generic Companies Report #3 (Q-Z)

List of Companies and Products under active Paragraph IV Certification
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an “Old Case” (terminated after November 1,…Read more

]]> 0 acf4783debb5fa3c3b86da218b7d331b gregoryglass updated 'Generic Companies Report #2 (F-P) ': The Paragraph Four Report ® Generic Companies Report #2 […] https://paragraphfour.com/activity/p/11805/ Thu, 09 Apr 2026 14:35:08 -0400 The Paragraph Four Report ®
Generic Companies Report #2 (F-P)

List of Companies and Products under active Paragraph IV Certification
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an “Old Case” (terminated after November 1,…Read more

]]> 0 05c28ed01a690fe11c9c033d91f77289 gregoryglass updated 'Branded Companies Report ': The Paragraph Four Report ® Branded Companies […] https://paragraphfour.com/activity/p/11804/ Thu, 09 Apr 2026 14:34:00 -0400 The Paragraph Four Report ®
Branded Companies Report

List of Companies with Products under active Paragraph IV Certification
Data includes total number and product and includes products that do not have a lawsuit filed (when verified by other sources). An Asterisk (*) indicates an “Old Case” (terminated after November 1, 2003)

ABBOTT LAB…Read more

]]> 0 15bb4382de00e4bb35149f81248723ec gregoryglass updated 'Colcrys®(colchicine) Tablets ': Colcrys®(colchicine) Tablets Company MUTUAL Date of […] https://paragraphfour.com/activity/p/11802/ Thu, 09 Apr 2026 14:28:01 -0400 Colcrys®(colchicine) Tablets
Company MUTUAL
Date of First Filing N/A (West Ward case) and December 23, 2011

Paragraph IV Applicant: West-Ward
Case Name: MUTUAL PHARMACEUTICAL COMPANY, INC. et al v. WEST-WARD PHARMACEUTICAL CORPORATION
Court/Case #: New Jersey District Court (njdc) 3:2011cv02276
Date Filed: 4/21/11
Judge: Cooper
Pro…Read more

]]> 0 3883142537e3c6b5872e486b9af5f52c gregoryglass updated 'Generic Companies Report #1 (A-E) ': The Paragraph Four Report ® Generic Companies Report #1 […] https://paragraphfour.com/activity/p/11801/ Thu, 09 Apr 2026 14:25:46 -0400 The Paragraph Four Report ®
Generic Companies Report #1 (A-E)

List of Companies and Products under active Paragraph IV Certification
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an “Old Case” (terminated after November 1,…Read more

]]> 0 406f4d2b6ecb5a3c018d547b1b563de9 gregoryglass updated 'Clenpiq®(sodium picosulfate, et al) Oral Solution ': Clenpiq®(sodium picosulfate, magnesium oxide and anhydrous […] https://paragraphfour.com/activity/p/11800/ Thu, 09 Apr 2026 14:25:12 -0400 Clenpiq®(sodium picosulfate, magnesium oxide and anhydrous citric acid) Oral Solution 
Company FERRING
Date of First Filing February 11, 2019

Paragraph IV Applicant: Lupin
Case Name: FERRING PHARMACEUTICALS INC et al v. LUPIN INC et al
Court/Case #: Delaware District Court (dedc) 1:2019cv00913
Date Filed: 5/16/19
Judge: Andrews
Produc…Read more

]]> 0 ff71e260ca91d95bd6a5fa879adcfe5e gregoryglass updated 'Generic Companies Report #1 (A-E) ': The Paragraph Four Report ® Generic Companies Report #1 […] https://paragraphfour.com/activity/p/11799/ Tue, 07 Apr 2026 14:52:43 -0400 The Paragraph Four Report ®
Generic Companies Report #1 (A-E)

List of Companies and Products under active Paragraph IV Certification
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an “Old Case” (terminated after November 1,…Read more

]]> 0 be5075b270b3f65dac19670bd5eccfa4 gregoryglass updated 'Omidria®(phenylephrine and ketorolac) Injection ': Omidria®(phenylephrine and ketorolac) Injection Company OMER […] https://paragraphfour.com/activity/p/11798/ Tue, 07 Apr 2026 14:51:54 -0400 Omidria®(phenylephrine and ketorolac) Injection
Company OMEROS
Date of First Filing May 29, 2015

Paragraph IV Applicant: Par
Case Name: OMEROS CORPORATION v. PAR STERILE PRODUCTS LLC et al
Court/Case #: Delaware District Court (dedc) 1:2015cv00773
Date Filed: 9/3/15
Judge: Andrews
Product Strength: 1%/0.3%
Litigated Patents…Read more

]]> 0 959b3a17d3bdd2d82fd24273e52106a8 gregoryglass updated 'Generic Companies Report #3 (Q-Z) ': The Paragraph Four Report ® Generic Companies Report #3 […] https://paragraphfour.com/activity/p/11797/ Tue, 07 Apr 2026 14:37:53 -0400 The Paragraph Four Report ®
Generic Companies Report #3 (Q-Z)

List of Companies and Products under active Paragraph IV Certification
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an “Old Case” (terminated after November 1,…Read more

]]> 0 b6984dc78a4eb44a824adefb39c50c94 gregoryglass updated 'Jardiance®(empagliflozin) Tablets ': Jardiance®(empagliflozin) Tablets Annual Sales $1.6B […] https://paragraphfour.com/activity/p/11796/ Tue, 07 Apr 2026 14:37:10 -0400 Jardiance®(empagliflozin) Tablets
Annual Sales $1.6B (product family) (as reported by Eli Lilly)
Company BOEHRINGER INGELHEIM
Date of First Filing August 1, 2018

Special Note: When these cases were filed, several of them also involve the combination product Glyxambi®(empagliflozin and linagliptin), Synjardy®(empagliflozin and me…Read more

]]> 0 f66fdb1f72a6dcc43c3f06ba218fb6aa gregoryglass updated 'Generic Companies Report #1 (A-E) ': The Paragraph Four Report ® Generic Companies Report #1 […] https://paragraphfour.com/activity/p/11795/ Tue, 07 Apr 2026 12:06:38 -0400 The Paragraph Four Report ®
Generic Companies Report #1 (A-E)

List of Companies and Products under active Paragraph IV Certification
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an “Old Case” (terminated after November 1,…Read more

]]> 0 08d1dfb8364a8e35c803bc9956e6d25e gregoryglass updated 'Abraxane®(paclitaxel) For Injection Suspension ': Abraxane®(paclitaxel) For Injection Suspension Company ABRAX […] https://paragraphfour.com/activity/p/11794/ Tue, 07 Apr 2026 12:06:04 -0400 Abraxane®(paclitaxel) For Injection Suspension
Company ABRAXIS
Date of First Filing December 11, 2015

Paragraph IV Applicant: Actavis
Case Name: ABRAXIS BIOSCIENCE LLC et al v. ACTAVIS LLC
Court/Case #: New Jersey District Court (njdc) 2:2016cv01925
Date Filed: 4/6/16
Judge: Vazquez
Product Strength: 100 mg/vial
Litigated Patents…Read more

]]> 0 26baae5eda492e6ac19390eb5a17c308 gregoryglass updated 'Generic Companies Report #3 (Q-Z) ': The Paragraph Four Report ® Generic Companies Report #3 […] https://paragraphfour.com/activity/p/11792/ Tue, 07 Apr 2026 11:46:11 -0400 The Paragraph Four Report ®
Generic Companies Report #3 (Q-Z)

List of Companies and Products under active Paragraph IV Certification
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an “Old Case” (terminated after November 1,…Read more

]]> 0 e6cdf98de81096f4492123e1512abcfb gregoryglass updated 'Last Month’s Paragraph IV Highlights ': March 2026 https://paragraphfour.com/activity/p/11789/ Thu, 02 Apr 2026 19:12:55 -0400 March 2026

]]> 0 6ec21275e435ce437111d5abb7336ac0 gregoryglass updated 'Myrbetriq®(mirabegron) Extended-release Tablets ': Myrbetriq®(mirabegron) Extended-release Tablets Annual […] https://paragraphfour.com/activity/p/11773/ Wed, 01 Apr 2026 15:54:36 -0400 Myrbetriq®(mirabegron) Extended-release Tablets
Annual Sales
Company ASTELLAS
Date of First Filing June 28, 2016

Special Summary Note #1: In 2016, Astellas brought PIV actions against 9 ANDA filers as listed below. By October 2020, all of the parties settled these original cases. On 11/24/20, the USPTO issued a new patent (10,842,780,…Read more

]]> 0 c4aebc9a90ee85449a336fb524d081e4 gregoryglass updated 'Jardiance®(empagliflozin) Tablets ': Jardiance®(empagliflozin) Tablets Annual Sales $1.6B […] https://paragraphfour.com/activity/p/11767/ Wed, 01 Apr 2026 14:54:12 -0400 Jardiance®(empagliflozin) Tablets
Annual Sales $1.6B (product family) (as reported by Eli Lilly)
Company BOEHRINGER INGELHEIM
Date of First Filing August 1, 2018

Special Note: When these cases were filed, several of them also involve the combination product Glyxambi®(empagliflozin and linagliptin), Synjardy®(empagliflozin and me…Read more

]]> 0 6c4b3d9124d09d0a49a97454a3fd3fac gregoryglass updated 'Injectafer®(ferric carboxymaltose) Injection ': Injectafer®(ferric carboxymaltose) Injection Company VIFOR […] https://paragraphfour.com/activity/p/11766/ Wed, 01 Apr 2026 14:48:17 -0400 Injectafer®(ferric carboxymaltose) Injection
Company VIFOR INTERNATIONAL
Date of First Filing March 27, 2019 and February 22, 2024 (50 mg/10 mL)

Paragraph IV Applicant: Mylan
Case Name: VIFOR (INTERNATIONAL) AG et al v. MYLAN LABORATORIES LTD
Court/Case #: New Jersey District Court (njdc) 3:2019cv13955
Date Filed: 6/18/19
Judge: Wolfs…Read more

]]> 0 564decd17892f1f21cafc958d896ed23 gregoryglass updated 'Generic Companies Report #3 (Q-Z) ': The Paragraph Four Report ® Generic Companies Report #3 […] https://paragraphfour.com/activity/p/11765/ Wed, 01 Apr 2026 13:24:05 -0400 The Paragraph Four Report ®
Generic Companies Report #3 (Q-Z)

List of Companies and Products under active Paragraph IV Certification
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an “Old Case” (terminated after November 1,…Read more

]]> 0 3f6ba2ca1f18e8c13467bc94ac1d7b71 gregoryglass updated 'Inter Partes Review List ': The Paragraph Four Report® Inter Partes Review List In […] https://paragraphfour.com/activity/p/11763/ Wed, 01 Apr 2026 13:11:18 -0400 The Paragraph Four Report®
Inter Partes Review List

In late 2012, the Inter Partes Review procedure went into effect allowing anyone to file a Petition with the US Patent and Trademark Office requesting that the USPTO invalidate an issued patent. Over time, this procedure became more common for Paragraph IV products and Orange Book Patents…Read more

]]> 0 715744ede820c0b41ebd5cfd6a532114 gregoryglass updated 'Generic Companies Report #2 (F-P) ': The Paragraph Four Report ® Generic Companies Report #2 […] https://paragraphfour.com/activity/p/11762/ Wed, 01 Apr 2026 13:04:37 -0400 The Paragraph Four Report ®
Generic Companies Report #2 (F-P)

List of Companies and Products under active Paragraph IV Certification
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an “Old Case” (terminated after November 1,…Read more

]]> 0 707e6da0713be21d4237dca6e60619a5 gregoryglass updated 'Tradjenta®(linagliptin) Tablets ': Tradjenta®(linagliptin) Tablets Jentadueto®(linagliptin a […] https://paragraphfour.com/activity/p/11761/ Wed, 01 Apr 2026 13:02:38 -0400 Tradjenta®(linagliptin) Tablets
Jentadueto®(linagliptin and metformin) Tablets
Jentadueto XR®(linagliptin and metformin) Extended-release Tablets
Annual Sales EUR 1.621B (global)
Company BOEHRINGER INGELHEIM
Date of First Filing May 5, 2015 (both products) and March 28, 2018 (Jentadueto XR)

Special Note: On 8/4/15, Boehringer In…Read more

]]> 0 61c352d636f67a734391c8fed4f47359 gregoryglass updated 'Jardiance®(empagliflozin) Tablets ': Jardiance®(empagliflozin) Tablets Annual Sales $1.6B […] https://paragraphfour.com/activity/p/11760/ Wed, 01 Apr 2026 12:50:23 -0400 Jardiance®(empagliflozin) Tablets
Annual Sales $1.6B (product family) (as reported by Eli Lilly)
Company BOEHRINGER INGELHEIM
Date of First Filing August 1, 2018

Special Note: When these cases were filed, several of them also involve the combination product Glyxambi®(empagliflozin and linagliptin), Synjardy®(empagliflozin and me…Read more

]]> 0 6710e32d6f48158f405ee35fffb26167 gregoryglass updated 'Generic Companies Report #1 (A-E) ': The Paragraph Four Report ® Generic Companies Report #1 […] https://paragraphfour.com/activity/p/11759/ Wed, 01 Apr 2026 12:30:48 -0400 The Paragraph Four Report ®
Generic Companies Report #1 (A-E)

List of Companies and Products under active Paragraph IV Certification
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an “Old Case” (terminated after November 1,…Read more

]]> 0 cf910598b2fc76eebf7156f2ea75f29d gregoryglass updated 'Invega Sustenna®(paliperidone) ER Inj Suspension ': Invega Sustenna®(paliperidone) Extended-release Injectable […] https://paragraphfour.com/activity/p/11758/ Wed, 01 Apr 2026 12:30:18 -0400 Invega Sustenna®(paliperidone) Extended-release Injectable Suspension
Annual Sales $3.1B (product family)
Company JANSSEN
Date of First Filing November 21, 2017

Paragraph IV Applicant: Teva
Case Name: JANSSEN PHARMACEUTICALS INC et al v. TEVA PHARMACEUTICALS USA INC et al
Court/Case #: Court of Appeals for the Federal Circuit (cafc)…Read more

]]> 0 9371467325e84366bf30f5cd78db2e74 gregoryglass updated 'Generic Companies Report #2 (F-P) ': The Paragraph Four Report ® Generic Companies Report #2 […] https://paragraphfour.com/activity/p/11757/ Wed, 01 Apr 2026 12:21:40 -0400 The Paragraph Four Report ®
Generic Companies Report #2 (F-P)

List of Companies and Products under active Paragraph IV Certification
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an “Old Case” (terminated after November 1,…Read more

]]> 0 671ac4472c1833962fb6bbc94eb1980d gregoryglass updated 'Kyprolis®(carfilzomib) For Injection ': Kyprolis®(carfilzomib) For Injection Annual Sales: […] https://paragraphfour.com/activity/p/11756/ Wed, 01 Apr 2026 12:15:35 -0400 Kyprolis®(carfilzomib) For Injection
Annual Sales: $948M
Company ONYX THERPEUTICS
Date of First Filing July 20, 2016 and October 5, 2017 (30mg/vial) and November 28, 2018 (10mg/vial)

Paragraph IV Applicant: Cipla
Case Name: ONYX THERAPEUTICS INC v. CIPLA LIMITED et al
Court/Case #: Court of Appeals for the Federal Circuit (cafc)…Read more

]]> 0 ed342e0bcab3363469fd2097136bc46b gregoryglass updated 'Generic Companies Report #3 (Q-Z) ': The Paragraph Four Report ® Generic Companies Report #3 […] https://paragraphfour.com/activity/p/11755/ Wed, 01 Apr 2026 12:01:29 -0400 The Paragraph Four Report ®
Generic Companies Report #3 (Q-Z)

List of Companies and Products under active Paragraph IV Certification
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an “Old Case” (terminated after November 1,…Read more

]]> 0 b82a76fe00129dbc924258751768fa18 gregoryglass updated 'Adempas®(riociguat) Tablets ': Adempas®(riociguat) Tablets Company BAYER Date of First […] https://paragraphfour.com/activity/p/11754/ Wed, 01 Apr 2026 12:00:38 -0400 Adempas®(riociguat) Tablets
Company BAYER
Date of First Filing October 10, 2017

Paragraph IV Applicant: Alembic
Case Name: ADVERIO PHARMA GMBH et al v. ALEMBIC PHARMACEUTICALS LTD et al
Court/Case #: Delaware District Court (dedc) 1:2018cv00073
Date Filed: 1/9/18
Judge: Salas
Product Strength: 0.5 mg, 1 mg, 1.5 mg, 2 mg and 2.5…Read more

]]> 0 d150f7a7add977640e2a58a8fe488850 gregoryglass updated 'Branded Companies Report ': The Paragraph Four Report ® Branded Companies […] https://paragraphfour.com/activity/p/11749/ Tue, 24 Mar 2026 15:36:15 -0400 The Paragraph Four Report ®
Branded Companies Report

List of Companies with Products under active Paragraph IV Certification
Data includes total number and product and includes products that do not have a lawsuit filed (when verified by other sources). An Asterisk (*) indicates an “Old Case” (terminated after November 1, 2003)

ABBOTT LAB…Read more

]]> 0 5a6c5382659c62722ef7625d2af991c9 gregoryglass updated 'Generic Companies Report #3 (Q-Z) ': The Paragraph Four Report ® Generic Companies Report #3 […] https://paragraphfour.com/activity/p/11748/ Tue, 24 Mar 2026 15:35:18 -0400 The Paragraph Four Report ®
Generic Companies Report #3 (Q-Z)

List of Companies and Products under active Paragraph IV Certification
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an “Old Case” (terminated after November 1,…Read more

]]> 0 d6128d5b60bae78c860343fa3a3a5d3c gregoryglass updated 'Generic Companies Report #2 (F-P) ': The Paragraph Four Report ® Generic Companies Report #2 […] https://paragraphfour.com/activity/p/11746/ Tue, 24 Mar 2026 15:14:51 -0400 The Paragraph Four Report ®
Generic Companies Report #2 (F-P)

List of Companies and Products under active Paragraph IV Certification
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an “Old Case” (terminated after November 1,…Read more

]]> 0 41d33e5c7eb36c20e77244f886789887 gregoryglass updated 'Generic Companies Report #3 (Q-Z) ': The Paragraph Four Report ® Generic Companies Report #3 […] https://paragraphfour.com/activity/p/11742/ Mon, 23 Mar 2026 19:39:33 -0400 The Paragraph Four Report ®
Generic Companies Report #3 (Q-Z)

List of Companies and Products under active Paragraph IV Certification
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an “Old Case” (terminated after November 1,…Read more

]]> 0 0c4cd7c42642d46f5870a2b80dc24dc4 gregoryglass updated 'Myrbetriq®(mirabegron) Extended-release Tablets ': Myrbetriq®(mirabegron) Extended-release Tablets Annual […] https://paragraphfour.com/activity/p/11733/ Fri, 20 Mar 2026 20:36:31 -0400 Myrbetriq®(mirabegron) Extended-release Tablets
Annual Sales
Company ASTELLAS
Date of First Filing June 28, 2016

Special Summary Note #1: In 2016, Astellas brought PIV actions against 9 ANDA filers as listed below. By October 2020, all of the parties settled these original cases. On 11/24/20, the USPTO issued a new patent (10,842,780,…Read more

]]> 0 15f1562adbd2b6d070e97980413b27a5 gregoryglass updated 'Jakafi®(ruxolitinib) Tablets ': Jakafi®(ruxolitinib) Tablets Annual Sales $2.79B Company […] https://paragraphfour.com/activity/p/11729/ Fri, 20 Mar 2026 19:38:21 -0400 Jakafi®(ruxolitinib) Tablets
Annual Sales $2.79B
Company INCYTE
Date of First Filing December 17, 2015

Special Note: After this product received its first PIV Notice in 2015, Incyte did not file any PIV cases until 2024 when a case against Apotex. We had placed this product as a “No Litigation Pending” product, and we keep that entry…Read more

]]> 0 c92c2887c430a475aef18d97d329b68a gregoryglass updated 'Gilenya®(fingolimod) Capsules ': Gilenya®(fingolimod) Capsules Annual Sales $359M Company […] https://paragraphfour.com/activity/p/11728/ Fri, 20 Mar 2026 19:10:12 -0400 Gilenya®(fingolimod) Capsules
Annual Sales $359M
Company NOVARTIS
Date of First Filing September 22, 2014 (0.5mg) and July 18, 2018 (0.25mg)

Special Summary: As this product has taken a few unusual turns with several waves of IPR petitions and PIV cases, a Summary is appropriate. The product started off with an Inter Partes Review…Read more

]]> 0 d762dbcf557c6a7d4c6835c907d064fc gregoryglass updated 'Eliquis®(apixaban) Tablets ': Eliquis®(apixaban) Tablets Company BRISTOL-MYERS Date of […] https://paragraphfour.com/activity/p/11726/ Fri, 20 Mar 2026 19:03:41 -0400 Eliquis®(apixaban) Tablets
Company BRISTOL-MYERS
Date of First Filing December 28, 2016

Special Note 1: On 4/5/17, Bristol-Myers filed PIV cases against 9 ANDA filers and on 4/10/17, PIV cases against 15 ANDA filers. All of these 24 cases were filed in Delaware and involve the 2.5mg and 5mg strengths. Please also see Special Note 2 below…Read more

]]> 0 9133d0a434bb002e41379b17e64bb3dd gregoryglass updated 'Colcrys®(colchicine) Tablets ': Colcrys®(colchicine) Tablets Company MUTUAL Date of […] https://paragraphfour.com/activity/p/11724/ Fri, 20 Mar 2026 18:53:37 -0400 Colcrys®(colchicine) Tablets
Company MUTUAL
Date of First Filing N/A (West Ward case) and December 23, 2011

Paragraph IV Applicant: West-Ward
Case Name: MUTUAL PHARMACEUTICAL COMPANY, INC. et al v. WEST-WARD PHARMACEUTICAL CORPORATION
Court/Case #: New Jersey District Court (njdc) 3:2011cv02276
Date Filed: 4/21/11
Judge: Cooper
Pro…Read more

]]> 0 e8924cd6a926a8c3571eb6ef29b63ee7 gregoryglass updated 'Bendeka®(bendamustine) Injection and Bendamustine ': Bendeka®(bendamustine) Injection Bendamustine […] https://paragraphfour.com/activity/p/11723/ Fri, 20 Mar 2026 18:47:41 -0400 Bendeka®(bendamustine) Injection
Bendamustine Injection
Annual Sales $168M
Company CEPHALON
Date of First Filing May 4, 2017 (Bendeka®(bendamustine) Injection) and July 17, 2018 (Bendeka Injection)

Special Note: While it is our normal protocol to separate distinct NDA products, these products merit an exception. The B…Read more

]]> 0 32d93b4879f8bd16fd860ebaea201514 gregoryglass updated 'Abraxane®(paclitaxel) For Injection Suspension ': Abraxane®(paclitaxel) For Injection Suspension Company ABRAX […] https://paragraphfour.com/activity/p/11721/ Fri, 20 Mar 2026 18:40:33 -0400 Abraxane®(paclitaxel) For Injection Suspension
Company ABRAXIS
Date of First Filing December 11, 2015

Paragraph IV Applicant: Actavis
Case Name: ABRAXIS BIOSCIENCE LLC et al v. ACTAVIS LLC
Court/Case #: New Jersey District Court (njdc) 2:2016cv01925
Date Filed: 4/6/16
Judge: Vazquez
Product Strength: 100 mg/vial
Litigated Patents…Read more

]]> 0 4ace35fdb9cfd98ad88ae4a0411dcc0c gregoryglass updated 'Generic Companies Report #1 (A-E) ': The Paragraph Four Report ® Generic Companies Report #1 […] https://paragraphfour.com/activity/p/11719/ Fri, 20 Mar 2026 15:39:03 -0400 The Paragraph Four Report ®
Generic Companies Report #1 (A-E)

List of Companies and Products under active Paragraph IV Certification
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an “Old Case” (terminated after November 1,…Read more

]]> 0 c676b14be70121de035063a5d21a9f38 gregoryglass updated 'Branded Companies Report ': The Paragraph Four Report ® Branded Companies […] https://paragraphfour.com/activity/p/11718/ Fri, 20 Mar 2026 15:38:25 -0400 The Paragraph Four Report ®
Branded Companies Report

List of Companies with Products under active Paragraph IV Certification
Data includes total number and product and includes products that do not have a lawsuit filed (when verified by other sources). An Asterisk (*) indicates an “Old Case” (terminated after November 1, 2003)

ABBOTT LAB…Read more

]]> 0 c3a4b1cf83948adc7b7b270d0f408e78 gregoryglass updated 'Generic Companies Report #1 (A-E) ': The Paragraph Four Report ® Generic Companies Report #1 […] https://paragraphfour.com/activity/p/11716/ Fri, 20 Mar 2026 15:14:47 -0400 The Paragraph Four Report ®
Generic Companies Report #1 (A-E)

List of Companies and Products under active Paragraph IV Certification
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an “Old Case” (terminated after November 1,…Read more

]]> 0 f5113d4ab6ec098a8f96d27a6eb88a49 gregoryglass updated 'Branded Companies Report ': The Paragraph Four Report ® Branded Companies […] https://paragraphfour.com/activity/p/11715/ Fri, 20 Mar 2026 15:14:25 -0400 The Paragraph Four Report ®
Branded Companies Report

List of Companies with Products under active Paragraph IV Certification
Data includes total number and product and includes products that do not have a lawsuit filed (when verified by other sources). An Asterisk (*) indicates an “Old Case” (terminated after November 1, 2003)

ABBOTT LAB…Read more

]]> 0 8041b7f393bfda22ba5081e59b14f865 gregoryglass updated 'Generic Companies Report #2 (F-P) ': The Paragraph Four Report ® Generic Companies Report #2 […] https://paragraphfour.com/activity/p/11713/ Wed, 18 Mar 2026 18:55:00 -0400 The Paragraph Four Report ®
Generic Companies Report #2 (F-P)

List of Companies and Products under active Paragraph IV Certification
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an “Old Case” (terminated after November 1,…Read more

]]> 0 1b524d1c5dc88596ebd146fbe5e096dd gregoryglass updated 'Branded Companies Report ': The Paragraph Four Report ® Branded Companies […] https://paragraphfour.com/activity/p/11712/ Wed, 18 Mar 2026 18:54:08 -0400 The Paragraph Four Report ®
Branded Companies Report

List of Companies with Products under active Paragraph IV Certification
Data includes total number and product and includes products that do not have a lawsuit filed (when verified by other sources). An Asterisk (*) indicates an “Old Case” (terminated after November 1, 2003)

ABBOTT LAB…Read more

]]> 0 2c0caab281c9b4a26bf718289cc8ae88 gregoryglass updated 'Generic Companies Report #1 (A-E) ': The Paragraph Four Report ® Generic Companies Report #1 […] https://paragraphfour.com/activity/p/11708/ Wed, 18 Mar 2026 15:52:03 -0400 The Paragraph Four Report ®
Generic Companies Report #1 (A-E)

List of Companies and Products under active Paragraph IV Certification
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an “Old Case” (terminated after November 1,…Read more

]]> 0 ab4c076a5e28cf9bb48d05b26d07a2c3 gregoryglass updated 'Branded Companies Report ': The Paragraph Four Report ® Branded Companies […] https://paragraphfour.com/activity/p/11707/ Wed, 18 Mar 2026 15:51:20 -0400 The Paragraph Four Report ®
Branded Companies Report

List of Companies with Products under active Paragraph IV Certification
Data includes total number and product and includes products that do not have a lawsuit filed (when verified by other sources). An Asterisk (*) indicates an “Old Case” (terminated after November 1, 2003)

ABBOTT LAB…Read more

]]> 0